Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

In this article MRK Follow your favorite stocksCREATE FREE ACCOUNT Dado Ruvic | Reuters Merck on Thursday reported first-quarter results that topped estimates on strong

Tag: products

Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

Facebook Has a Health Scam Problem

Your Doctor’s Notes Might Be Written by an A.I. Algorithm. Here’s What to Know.

Cardio vs Strength Training: Do I Really Need to Do Both?